Steven Zeig

2.5k total citations
23 papers, 1.2k citations indexed

About

Steven Zeig is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, Steven Zeig has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Nephrology and 3 papers in Genetics. Recurrent topics in Steven Zeig's work include Erythropoietin and Anemia Treatment (9 papers), Iron Metabolism and Disorders (7 papers) and Parathyroid Disorders and Treatments (5 papers). Steven Zeig is often cited by papers focused on Erythropoietin and Anemia Treatment (9 papers), Iron Metabolism and Disorders (7 papers) and Parathyroid Disorders and Treatments (5 papers). Steven Zeig collaborates with scholars based in United States, United Kingdom and Switzerland. Steven Zeig's co-authors include Alexander R. Cobitz, K. Shashi Kant, Louis Holdstock, Brendan M. Johnson, Amy M. Meadowcroft, John J. Lepore, Delyth Jones, Bruce N. Garrett, Isaac Teitelbaum and Eduardo Slatopolsky and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American Society of Nephrology.

In The Last Decade

Steven Zeig

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Zeig United States 11 751 637 275 246 146 23 1.2k
Konstantin Gurevich United States 6 234 0.3× 156 0.2× 65 0.2× 58 0.2× 78 0.5× 8 399
Thilo Krueger Germany 7 263 0.4× 111 0.2× 78 0.3× 324 1.3× 34 0.2× 8 641
Michael Schömig Germany 11 267 0.4× 253 0.4× 79 0.3× 25 0.1× 55 0.4× 22 506
Kimberly B. Zumbrennen‐Bullough United States 9 340 0.5× 474 0.7× 371 1.3× 334 1.4× 49 0.3× 9 977
Soichiro Tajima Japan 15 69 0.1× 209 0.3× 142 0.5× 107 0.4× 71 0.5× 27 688
MJ Koury United States 9 71 0.1× 761 1.2× 287 1.0× 12 0.0× 183 1.3× 13 1.1k
Kin-Hung P. Yu United States 8 246 0.3× 605 0.9× 259 0.9× 5 0.0× 304 2.1× 19 1.1k
Jin Nakamura Japan 9 353 0.5× 109 0.2× 69 0.3× 10 0.0× 71 0.5× 9 759
Pia Glas-Greenwalt United States 17 44 0.1× 273 0.4× 37 0.1× 109 0.4× 160 1.1× 29 933
Olga Mannarino Italy 14 73 0.1× 77 0.1× 54 0.2× 69 0.3× 47 0.3× 19 463

Countries citing papers authored by Steven Zeig

Since Specialization
Citations

This map shows the geographic impact of Steven Zeig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Zeig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Zeig more than expected).

Fields of papers citing papers by Steven Zeig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Zeig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Zeig. The network helps show where Steven Zeig may publish in the future.

Co-authorship network of co-authors of Steven Zeig

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Zeig. A scholar is included among the top collaborators of Steven Zeig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Zeig. Steven Zeig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harlin, Stuart, Eri Fukaya, Julianne Stoughton, et al.. (2023). VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers. Journal of Vascular Surgery Venous and Lymphatic Disorders. 11(4). 692–699.e1. 2 indexed citations
3.
Čižman, Borut, et al.. (2018). An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects. Kidney International Reports. 3(4). 841–850. 26 indexed citations
4.
5.
Umanath, Kausik, Diana Jalal, Barbara Greco, et al.. (2015). Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD. Journal of the American Society of Nephrology. 26(10). 2578–2587. 74 indexed citations
6.
Holdstock, Louis, Amy M. Meadowcroft, Brendan M. Johnson, et al.. (2015). Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia. Journal of the American Society of Nephrology. 27(4). 1234–1244. 156 indexed citations
7.
Lewis, Julia B., Mohammed Sika, Mark J. Koury, et al.. (2014). Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis. Journal of the American Society of Nephrology. 26(2). 493–503. 138 indexed citations
8.
Block, Geoffrey A., Ogo Egbuna, Steven Zeig, et al.. (2014). The evaluation of denosumab safety in patients with chronic kidney disease: An open-label study.. Journal of Clinical Oncology. 32(15_suppl). e20649–e20649. 5 indexed citations
9.
Block, Geoffrey A., Ogo Egbuna, Steven Zeig, et al.. (2014). Safety of Denosumab (Dmab) in Patients (Pts) with Stage 4 or Stage 5D Chronic Kidney Disease (Ckd). Annals of Oncology. 25. iv528–iv528. 2 indexed citations
10.
Dwyer, Jamie P., Mohammed Sika, Gerald Schulman, et al.. (2013). Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial. American Journal of Kidney Diseases. 61(5). 759–766. 51 indexed citations
11.
Besarab, Anatole, Steven Zeig, Edouard Martin, et al.. (2012). An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients. BMC Nephrology. 13(1). 95–95. 8 indexed citations
12.
Schiller, Brigitte, Steven Zeig, Nathan W. Levin, et al.. (2011). 274 Safety and Efficacy of Peginesatide for Treatment of Anemia in Hemodialysis Patient Previously on Epoetin Alfa. American Journal of Kidney Diseases. 57(4). B85–B85. 1 indexed citations
13.
Schiller, Brigitte, Pablo E. Pérgola, Steven Zeig, et al.. (2010). 266: Long-Term Clinical Experience With Hematide™. American Journal of Kidney Diseases. 55(4). B98–B98. 1 indexed citations
14.
Mehrotra, Rajnish, Kévin Martin, Steven Fishbane, et al.. (2008). Higher Strength Lanthanum Carbonate Provides Serum Phosphorus Control With a Low Tablet Burden and Is Preferred by Patients and Physicians. Clinical Journal of the American Society of Nephrology. 3(5). 1437–1445. 38 indexed citations
15.
Block, Geoffrey A., et al.. (2008). Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrology Dialysis Transplantation. 23(7). 2311–2318. 81 indexed citations
16.
Geronemus, Robert, Pablo E. Pérgola, Brigitte Schiller, et al.. (2008). 84: Interim Evaluation of Long-Term Safety and Tolerability of Hematide™ During Maintenance Treatment of Anemia in Patients with CKD on Hemodialysis. American Journal of Kidney Diseases. 51(4). B48–B48. 1 indexed citations
17.
Levin, Nathan W., Steven Fishbane, Steven Zeig, et al.. (2007). Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA). The Lancet. 370(9596). 1415–1421. 114 indexed citations
18.
Bleyer, Anthony J., Steven K. Burke, Maureen Dillon, et al.. (1999). A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. American Journal of Kidney Diseases. 33(4). 694–701. 204 indexed citations
19.
Manis, Thomas, et al.. (1979). ORAL SORBENTS IN UREMIA AND DIABETES; CHARCOAL-INDUCED HYPOLIPIDEMIA. ASAIO Journal. 25(1). 19–23. 5 indexed citations
20.
Ea, Friedman, et al.. (1979). Hypolipidemic effect of low-dose oral charcoal in diabetic rats.. PubMed. 11(2). 79–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantin Gurevich Breakdown of academic impact, for papers by Thilo Krueger Breakdown of academic impact, for papers by Michael Schömig Breakdown of academic impact, for papers by Kimberly B. Zumbrennen‐Bullough Breakdown of academic impact, for papers by Soichiro Tajima Breakdown of academic impact, for papers by MJ Koury Breakdown of academic impact, for papers by Kin-Hung P. Yu Breakdown of academic impact, for papers by Jin Nakamura Breakdown of academic impact, for papers by Pia Glas-Greenwalt Breakdown of academic impact, for papers by Olga Mannarino
Rankless by CCL
2026